KR102441636B1 - Ns3 포획 펩타이드를 사용한 대상체 항-hcv 항체 검출 검정 - Google Patents

Ns3 포획 펩타이드를 사용한 대상체 항-hcv 항체 검출 검정 Download PDF

Info

Publication number
KR102441636B1
KR102441636B1 KR1020177014533A KR20177014533A KR102441636B1 KR 102441636 B1 KR102441636 B1 KR 102441636B1 KR 1020177014533 A KR1020177014533 A KR 1020177014533A KR 20177014533 A KR20177014533 A KR 20177014533A KR 102441636 B1 KR102441636 B1 KR 102441636B1
Authority
KR
South Korea
Prior art keywords
delete delete
hcv
gly
thr
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020177014533A
Other languages
English (en)
Korean (ko)
Other versions
KR20170072338A (ko
Inventor
존 프로스트코
안토니 에스. 뮤어오프
크리스 마로닉
Original Assignee
아보트 러보러터리즈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아보트 러보러터리즈 filed Critical 아보트 러보러터리즈
Publication of KR20170072338A publication Critical patent/KR20170072338A/ko
Application granted granted Critical
Publication of KR102441636B1 publication Critical patent/KR102441636B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/186—Hepatitis C; Hepatitis NANB
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
KR1020177014533A 2014-10-29 2015-10-28 Ns3 포획 펩타이드를 사용한 대상체 항-hcv 항체 검출 검정 Active KR102441636B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462072266P 2014-10-29 2014-10-29
US62/072,266 2014-10-29
PCT/US2015/057845 WO2016069762A2 (en) 2014-10-29 2015-10-28 Subject anti-hcv antibody detection assays employing ns3 capture peptides

Publications (2)

Publication Number Publication Date
KR20170072338A KR20170072338A (ko) 2017-06-26
KR102441636B1 true KR102441636B1 (ko) 2022-09-13

Family

ID=54479000

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177014533A Active KR102441636B1 (ko) 2014-10-29 2015-10-28 Ns3 포획 펩타이드를 사용한 대상체 항-hcv 항체 검출 검정

Country Status (7)

Country Link
US (3) US10088483B2 (enExample)
EP (1) EP3213083B1 (enExample)
JP (2) JP6821562B2 (enExample)
KR (1) KR102441636B1 (enExample)
CN (1) CN107110868B (enExample)
ES (1) ES2828713T3 (enExample)
WO (1) WO2016069762A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107110868B (zh) 2014-10-29 2020-08-21 雅培制药有限公司 采用ns3捕获肽的受试者抗hcv抗体检测测定
ES2961462T3 (es) 2017-07-27 2024-03-12 Roche Diagnostics Gmbh Proteína de fusión multiepítopo de un antígeno del VHC y usos de la misma
CN112341527B (zh) * 2020-09-16 2021-08-31 菲鹏生物股份有限公司 Hcv重组抗原及应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002096941A2 (fr) 2001-05-28 2002-12-05 bioMérieux Polypeptide reagissant avec les anticoprs de patients infectes par le vhc et utilisations

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273115B1 (en) 1986-10-22 1994-09-07 Abbott Laboratories Chemiluminescent acridinium and phenanthridinium salts
US5006309A (en) 1988-04-22 1991-04-09 Abbott Laboratories Immunoassay device with liquid transfer between wells by washing
US5089424A (en) 1988-06-14 1992-02-18 Abbott Laboratories Method and apparatus for heterogeneous chemiluminescence assay
US5241070A (en) 1988-09-26 1993-08-31 Ciba Corning Diagnostics Corp. Nucleophilic polysubstituted aryl acridinium esters and uses thereof
SE462454B (sv) 1988-11-10 1990-06-25 Pharmacia Ab Maetyta foer anvaendning i biosensorer
US5063081A (en) 1988-11-14 1991-11-05 I-Stat Corporation Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor
PL172133B1 (pl) 1990-04-04 1997-08-29 Chiron Corp Sposób tworzenia kombinacji antygenów wirusowego zapalenia watroby typu C (HCV) i sposób wykrywania przeciwcial przeciw wirusowemu zapaleniu watroby typu C (HCV)
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
US5135785A (en) 1990-08-13 1992-08-04 Colgate-Palmolive Company Pouch containers and films therefor
US5135875A (en) 1990-08-15 1992-08-04 Abbott Laboratories Protein precipitation reagent
CA2048302A1 (en) 1990-08-15 1992-02-16 Victoria P. Meucci Solubilization reagent for biological test samples
CA2069530A1 (en) 1991-06-03 1992-12-04 Cass J. Grandone Reagent pack for immunoassays
US5352803A (en) 1992-03-30 1994-10-04 Abbott Laboratories 5(6)-methyl substituted fluorescein derivatives
DE69328622T2 (de) 1992-03-30 2001-02-08 Abbott Laboratories, Abbott Park Reagenzien und verfahren zum nachweis und zur quantifizierung von thyroxin in flüssigen proben
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6537749B2 (en) 1998-04-03 2003-03-25 Phylos, Inc. Addressable protein arrays
DK1071955T4 (da) * 1998-04-17 2009-06-15 Innogenetics Nv Forbedrede immundiagnostiske assays, som anvender reduktionsmidler
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
AU4025300A (en) 1999-03-24 2000-10-09 Packard Bioscience Company Continuous porous matrix arrays
US7101683B2 (en) * 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
US7419821B2 (en) 2002-03-05 2008-09-02 I-Stat Corporation Apparatus and methods for analyte measurement and immunoassay
US20040018577A1 (en) 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay
US20040152070A1 (en) * 2003-02-04 2004-08-05 Shah Dinesh O. Method of detection of HCV antibodies in combination assay or sole antibody assay
US20050014136A1 (en) 2003-05-28 2005-01-20 Innogenetics N.V. Modified HCV NS5
US7682833B2 (en) 2003-09-10 2010-03-23 Abbott Point Of Care Inc. Immunoassay device with improved sample closure
US7723099B2 (en) 2003-09-10 2010-05-25 Abbott Point Of Care Inc. Immunoassay device with immuno-reference electrode
US7883855B2 (en) 2006-07-21 2011-02-08 Abbott Laboratories Immunosuppressant drug extraction reagent for immunoassays
US8865398B2 (en) * 2006-09-01 2014-10-21 Abbott Laboratories Combination hepatitis C virus antigen and antibody detection method
US7858752B2 (en) 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
US7906293B2 (en) 2007-04-09 2011-03-15 Abbott Laboratories Acridinium phenyl esters useful in the analysis of biological
CN101477126A (zh) * 2008-09-24 2009-07-08 湖南景达生物工程有限公司 一种丙型肝炎病毒抗原抗体联合检测的方法
US20120009196A1 (en) 2010-07-08 2012-01-12 Abbott Laboratories Monoclonal antibodies against hepatitis c virus core protein
JP5828728B2 (ja) * 2011-09-28 2015-12-09 株式会社日立ハイテクノロジーズ 自動分析装置
CA2906417C (en) 2013-03-14 2022-06-21 Robert Ziemann Hcv core lipid binding domain monoclonal antibodies
BR112015023355A8 (pt) 2013-03-14 2018-01-30 Abbott Lab antígenos recombinantes ns3 de hcv e mutantes dos mesmos para detecção de anticorpos aprimorada.
EP2968526A4 (en) * 2013-03-14 2016-11-09 Abbott Lab HCV ANTIGEN ANTIBODY COMBINATION TEST AND METHOD AND COMPOSITIONS FOR USE THEREOF
CN103792354B (zh) * 2014-01-28 2015-11-25 中国医学科学院基础医学研究所 一种检测丙型肝炎病毒抗体的微流控纸基芯片及其制备方法
CN107110868B (zh) 2014-10-29 2020-08-21 雅培制药有限公司 采用ns3捕获肽的受试者抗hcv抗体检测测定

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002096941A2 (fr) 2001-05-28 2002-12-05 bioMérieux Polypeptide reagissant avec les anticoprs de patients infectes par le vhc et utilisations

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Bian Y et al., PLOS ONE (2013.07.24.), vol 8, no 7, e70214, pp 1-8.
Wu F-B et al., Journal of Medical Microbiology (2008.08.01.), vol 57, no 8, pp 947-953.

Also Published As

Publication number Publication date
JP2021063827A (ja) 2021-04-22
US11340230B2 (en) 2022-05-24
JP6821562B2 (ja) 2021-01-27
KR20170072338A (ko) 2017-06-26
US10816551B2 (en) 2020-10-27
US20190064169A1 (en) 2019-02-28
JP2017534056A (ja) 2017-11-16
US10088483B2 (en) 2018-10-02
EP3213083B1 (en) 2020-08-19
US20160131653A1 (en) 2016-05-12
EP3213083A2 (en) 2017-09-06
WO2016069762A3 (en) 2016-07-07
BR112017009029A2 (pt) 2018-02-06
WO2016069762A2 (en) 2016-05-06
CN107110868B (zh) 2020-08-21
CN107110868A (zh) 2017-08-29
ES2828713T3 (es) 2021-05-27
US20210041442A1 (en) 2021-02-11

Similar Documents

Publication Publication Date Title
US9841427B2 (en) HCV antigen-antibody combination assay and methods and compositions for use therein
US9790478B2 (en) HCV NS3 recombinant antigens and mutants thereof for improved antibody detection
JP2021533384A (ja) バイオマーカーを検出する方法
JP2010502959A (ja) 組み合わせｃ型肝炎ウイルス抗原及び抗体検出法
US11340230B2 (en) Subject anti-HCV antibody detection assays employing NS3 capture peptides
JP2023017986A (ja) 自己抗体の直接イムノアッセイ測定法
JP6292564B2 (ja) 肝細胞がん患者の再発リスク予測を補助する方法、装置、コンピュータプログラム製品及びキット
KR101893244B1 (ko) 당뇨병에 대한 신규 바이오마커 및 그의 용도
JP5456056B2 (ja) 体液中のｉｆｉ１６の検出
US20130330745A1 (en) Methods of prognosis and diagnosis in sepsis
JPH08500673A (ja) Ｈｃｖ感染固体においてインターフェロン療法の有効性を監視する方法
BR112017009029B1 (pt) Método de detecção de infecção pelo vírus da hepatite c (hcv) em um indivíduo, kit e composição
KR20260003222A (ko) 말기 간세포 암종의 진단

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20170526

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20201027

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20211208

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20220621

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220905

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220906

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20250625

Start annual number: 4

End annual number: 4